In this study, we found a new DNA aptamer/vitamin C complex, NXP031, ameliorated against CCH-induced cognitive impairment and BBB disruption by increasing antioxidant enzyme activity through potentiation of the Nrf2-ARE pathway and reducing CCH-induced ROS production. Here, NFE2L2 is linked to Cognitive impairment.